NCT01906424

Brief Summary

This study is to determine if non-invasive electrical stimulation of the spinal cord can help improve hand and arm function in people with paralysis who suffered a cervical spinal cord injury.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 24, 2013

Completed
2.7 years until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
Last Updated

January 24, 2017

Status Verified

April 1, 2016

Enrollment Period

9 months

First QC Date

July 16, 2013

Last Update Submit

January 20, 2017

Conditions

Keywords

spinal cord injuryquadriplegiatetraplegiastimulation

Outcome Measures

Primary Outcomes (1)

  • Improvement in sensorimotor function in arms and hands

    Subjects will be tested by several measures of sensory and motor function, as well as self-assessments regarding quality of life and independence, at the beginning of the study and at each testing session. These tests include: American Spinal Injury Association (ASIA) scoring system. Box and block CUE (Capabilities of Upper Extremity) GRASSP (Graded Redefined Assessment of Strength, Sensibility and Prehension) SCIM (Spinal Cord Independence Measure) Ashworth Spasticity scale: Penn Spasm Frequency VAS (Visual Analog Scale) for Spasticity)

    12 weeks

Study Arms (3)

Control Grp#1: Training w/ and w/o Stim

OTHER

Control- Group #1: 4 weeks training without any transcutaneous electrical stimulation followed by 2 weeks of training plus transcutaneous electrical spinal cord stimulation applied to one or two locations of the cervical (neck) region of the spinal cord.

Device: Transcutaneous Electrical Spinal Cord Stimulation

Grp#2: Training+Single Site Stimulation

ACTIVE COMPARATOR

Group #2: Four weeks of training plus transcutaneous electrical spinal cord stimulation applied to one location along the cervical (neck) region of the spinal cord; followed by 2 weeks of training without stimulation

Device: Transcutaneous Electrical Spinal Cord Stimulation

Grp #3: Training + Two Site Stimualtion

ACTIVE COMPARATOR

Group #3: Four weeks of training plus transcutaneous electrical spinal cord stimulation applied to two locations along the cervical (neck) region of the spinal cord; followed by 2 weeks of training without stimulation

Device: Transcutaneous Electrical Spinal Cord Stimulation

Interventions

A prototype device that delivers transcutaneous electrical stimulation will be used to stimulate the cervical spinal cord.

Also known as: Prototype device
Control Grp#1: Training w/ and w/o StimGrp #3: Training + Two Site StimualtionGrp#2: Training+Single Site Stimulation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Spinal cord injury 1 or more years prior
  • Non progressive SCI at C7 or higher
  • Half of key muscles below neurological level having a motor score of less than 2/5
  • Ability to commit to home exercises and 12 week participation
  • Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate participation in upper extremity rehabilitation or testing activities
  • Not dependent on ventilation support
  • No painful musculoskeletal dysfunction, unhealed fracture, pressure sore, or urinary tract infection that might interfere with upper extremity rehabilitation or testing activities
  • No clinically significant depression or ongoing drug abuse
  • Adequate social support network to be able to participate in weekly training and assessment sessions for the duration of the 12 week study period
  • No current anti-spasticity regimen
  • Must not have received botox injections in the prior six months
  • Be unable to use upper extremity for functional tasks

You may not qualify if:

  • Pregnancy
  • No functional segmental reflexes below the lesion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of California Los Angeles

Los Angeles, California, 90095, United States

Location

Strides SCI Functional Fitness

San Juan Capistrano, California, 92675, United States

Location

MeSH Terms

Conditions

ParalysisSpinal Cord InjuriesQuadriplegia

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Victor R Edgerton, PhD

    University of California, Los Angeles

    STUDY CHAIR
  • Nicholas Terrafranca, DPM

    NeuroEnabling Technologies, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2013

First Posted

July 24, 2013

Study Start

April 1, 2016

Primary Completion

December 31, 2016

Study Completion

December 31, 2016

Last Updated

January 24, 2017

Record last verified: 2016-04

Locations